RQ BIOTECHNOLOGY LIMITED
Get an alert when RQ BIOTECHNOLOGY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£8.7m
-19.9% vs 2025
Net assets
£6.9m
-42.6% first positive since 2022
Employees
14
+16.7% highest in 4 filed years
Profit before tax
-£5.8m
-24.3% lowest in 3 filed years
Net assets
4-year trend · vs Health Care median
Accounts
4-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31
| Metric | Trend | 2022-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | Δ vs prior |
|---|---|---|---|---|---|---|
| Turnover | — | £12,059,429 | £0 | £322,545 | — | |
| Operating profit | — | £5,605,640 | -£5,247,270 | -£5,887,364 | -12.2% | |
| Profit before tax | — | £5,509,735 | -£4,703,269 | -£5,848,364 | -24.3% | |
| Net profit | — | £5,146,083 | -£3,550,011 | -£5,084,262 | -43.2% | |
| Cash | £678,465 | £15,827,176 | £10,892,690 | £8,721,513 | -19.9% | |
| Total assets less current liabilities | -£904,076 | £15,490,637 | £12,091,286 | £6,935,129 | -42.6% | |
| Net assets | -£904,076 | £15,439,251 | £12,091,286 | £6,935,129 | -42.6% | |
| Equity | -£904,076 | £15,439,251 | £12,091,286 | £6,935,129 | -42.6% | |
| Average employees | 1 | 11 | 12 | 14 | +16.7% | |
| Wages | — | £1,754,229 | £1,487,610 | £1,679,480 | +12.9% | |
| Directors' remuneration | — | £591,986 | £271,460 | £285,660 | +5.2% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|---|
| Operating margin | — | 46.5% | — | — | |
| Net margin | — | 42.7% | — | — | |
| Return on capital employed | — | 36.2% | -43.4% | -84.9% | |
| Current ratio | — | 15.33x | 13.75x | 3.23x | |
| Interest cover | — | 7.44x | -69.44x | -24.49x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on a going concern basis, which assumes that the Company will continue as a going concern for the foreseeable future being a period of at least twelve months from the date of approval of these financial statements.”
Significant events
- “In June 2026, RQ Biotechnology Holdings Limited secured £85.5m series A funding which will be utilised for the clinical development of the Company's lead assets. On the same date, the convertible loan note in the parent company was converted into series A preferred shares. In consideration for the first tranche of funding totalling £40.2m and the loan conversion, RQ Biotechnology Holdings Limited issued 2,028,585 series A preferred shares.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| TERLOUW, Clare Elizabeth | Director | 2021-03-26 | Dec 1973 | British,Canadian |
| WESTBY, Michael, Dr | Director | 2021-03-26 | Jun 1966 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BALLOU, William Ripley | Director | 2023-01-01 | 2024-04-09 |
| CHOLAT, Jacques | Director | 2023-01-01 | 2024-04-09 |
| FRY, Hugo Rupert Alexander | Director | 2022-06-27 | 2023-09-04 |
| OSBOURN, Jane | Director | 2021-03-26 | 2022-11-02 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Rq Biotechnology Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-04-08 | Active |
| Lifearc | Corporate entity | Shares 25–50%, Voting 25–50% | 2023-09-05 | Ceased 2024-04-08 |
Filing timeline
Last 20 of 37 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-09-06 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-25 | AA | accounts | Accounts with accounts type full | |
| 2026-03-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-28 | AA | accounts | Accounts with accounts type full | |
| 2025-03-31 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-09-06 | MA | incorporation | Memorandum articles | |
| 2024-07-25 | AA | accounts | Accounts with accounts type full | |
| 2024-06-05 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2024-06-05 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-04-09 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-09 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-11-06 | SH03 | capital | Capital return purchase own shares | |
| 2023-10-25 | AA | accounts | Accounts with accounts type full | |
| 2023-10-09 | SH08 | capital | Capital name of class of shares | |
| 2023-10-06 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2023-10-05 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2023-10-05 | TM01 | officers | Termination director company with name termination date | |
| 2023-06-30 | CH01 | officers | Change person director company with change date | |
| 2023-06-29 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-03-31 | AD03 | address | Move registers to sail company with new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.